Enhancing Accuracy of Newborn Screening for 21OHD: Strategic Use of 21-Deoxycortisol in a Large-Scale Tokyo Cohort
The Journal of Clinical Endocrinology & Metabolism · 2026
DOI: 10.1210/clinem/dgaf506 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Haruki Yamano und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Developmental Biology, Institute of Science Tokyo School of Medicine, Bunkyo-ku, Tokyo 113-8510, Japan. Hauptthemen laut MEDLINE: Neonatal Screening, Adrenal Hyperplasia, Congenital, Cortodoxone. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Context
Newborn screening (NBS) for 21-hydroxylase deficiency (21OHD) has historically shown high false-positive (FP) rates, especially in low-birth-weight (LBW) infants. In 2022, we proposed a second-tier liquid chromatography–tandem mass spectrometry (LC-MS/MS)–based algorithm to improve screening specificity; however, its real-world performance remains unassessed prospectively.
Objective
This work aimed to prospectively evaluate our LC-MS/MS–based screening algorithm for 21OHD and develop a refined version addressing newly identified clinical limitations.
Methods
We prospectively analyzed 326 006 newborns screened in Tokyo from 2021 to 2025. Based on the findings, a revised algorithm was retrospectively validated in 946 246 newborns screened between 2015 and 2025.
Results
The original algorithm showed 100% sensitivity but lower-than-expected positive predictive values (PPVs) (9.0% for initial positives; 44.8% for final referrals). This was mainly due to FPs in LBW infants, who made up 75.7% of initial positives despite being unaffected. Steroid profiling showed elevated 21-deoxycortisol (21DOC) in all true positives but undetectable levels in 99.2% of LBW FPs. A refined algorithm prioritized a low 21DOC cutoff as the primary exclusion criterion, with the 11-deoxycortisol to 17α-hydroxyprogesterone (11DOC/17OHP) ratio as a secondary safeguard. This revision reduced LBW-related recalls by more than 99% and raised PPVs to 87.2% for initial positives and 89.1% for final referrals.
Conclusion
This large-scale prospective study showed that a refined LC-MS/MS algorithm using 21DOC and 11DOC/17OHP greatly improved 21OHD screening specificity, eliminating LBW-related FPs and enhancing NBS efficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics and Developmental Biology, Institute of Science Tokyo School of Medicine, Bunkyo-ku, Tokyo 113-8510, Japan.
- Tokyo Health Service Association, Newborn Screening, Tokyo, Japan.
- Division of Endocrinology and Metabolism, National Center for Child Health and Development (NCCHD), Setagaya-ku, Tokyo 157-8535, Japan.
ORCID-Profile: Haruki Yamano, Shizuka Kirino, Yoko Saito, Eriko Adachi, Gau Maki, Hisae Nakatani, Atsumi Tsuji-Hosokawa, Kenichi Kashimada, Kei Takasawa
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Yamano, H., Watanabe, K., Komatsu, M., Hashimoto, A., Suzuki, Y., Kirino, S., Saito, Y., Adachi, E., Maki, G., Nakatani, H., Tsuji-Hosokawa, A., Kashimada, K., Ishige, N., & Takasawa, K. (2026). Enhancing Accuracy of Newborn Screening for 21OHD: Strategic Use of 21-Deoxycortisol in a Large-Scale Tokyo Cohort. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf506
Vancouver
Yamano H, Watanabe K, Komatsu M, Hashimoto A, Suzuki Y, Kirino S, et al. Enhancing Accuracy of Newborn Screening for 21OHD: Strategic Use of 21-Deoxycortisol in a Large-Scale Tokyo Cohort. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf506
BibTeX
@article{Yamano2026,
author = {Yamano, Haruki and Watanabe, Kazuhiro and Komatsu, Minami and Hashimoto, Atsuko and Suzuki, Yuri and Kirino, Shizuka and Saito, Yoko and Adachi, Eriko and Maki, Gau and Nakatani, Hisae and Tsuji-Hosokawa, Atsumi and Kashimada, Kenichi and Ishige, Nobuyuki and Takasawa, Kei},
title = {Enhancing Accuracy of Newborn Screening for 21OHD: Strategic Use of 21-Deoxycortisol in a Large-Scale Tokyo Cohort},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgaf506}
}
EUVIMED